26.86USD-0.67%Mkt Cap: 93.36M USDP/E: —Last update: 2026-06-01
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagio…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap93.36M USD
Enterprise Value110.63M USD
Revenue (TTM)27.70M USD
Gross Profit7.43M USD
Net Income (TTM)-43.32M USD
Revenue/Share10.84 USD
Last Price26.86 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees92
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-12.46
PEG—
EV/EBITDA—
EV/Revenue3.99
P/S3.32
P/B2.54
EPS (TTM)-22.92
EPS (Forward)-2.13
52W Range
9.00039% of range54.29
52W High54.29 USD
52W Low9.000 USD
Profitability
Gross Margin44.24%
Oper. Margin-120.01%
EBITDA Margin0.00%
Profit Margin-257.93%
ROE-111.41%
ROA-33.22%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-22.59M USD
CapEx (TTM)8.00M USD
FCF Margin-123.97%
FCF Yield-36.78%
Net Debt20.95M USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity0.90
Current Ratio2.79
Quick Ratio1.75
Book Value/Sh10.42 USD
Cash/Share9.200 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJul 2, 2025
Analyst Consensus
Rating1.1 (Strong Buy)
Target (Mean)57.71 USD
Target Range48.00 USD – 75.00 USD
# Analysts7
Ownership
Shares Out.3.48M
Float1.47M
Insiders53.81%
Institutions35.42%
Short Interest
Short Ratio1.4d
Short % Float1.81%
Short % Out.0.89%
Shares Short31.02K
Short (prev mo.)45.96K
Technical
SMA 5024.15 (+11.2%)
SMA 20026.19 (+2.5%)
Beta3.33
S&P 52W Chg27.94%
Avg Vol (30d)21.79K
Avg Vol (10d)25.78K
Technical Indicators
RSI (14)57.7
MACD0.7485
MACD Signal0.8410
MACD Hist.-0.0925
BB Upper28.19 USD
BB Middle26.35 USD
BB Lower24.51 USD
BB Width13.96%
ATR (14)1.304 USD
Vol Ratio (20d)0.23x